Anavex secures approval to start Phase llb/lll trial of ANAVEX 2-73
Anavex Life Sciences has received approval from the Australian Human Research Ethics Committee to begin a Phase llb/lll clinical trial…
Anavex Life Sciences ANAVEX 2-73 Alzheimer’s disease
